This topical formulation combines Clobetasol Propionate 0.05% w/v, a potent corticosteroid, with Salicylic Acid 6.0% w/v, a keratolytic agent. It is designed to treat chronic inflammatory skin conditions such as psoriasis, eczema, and hyperkeratotic disorders. Clobetasol Propionate reduces inflammation, redness, and itching, while Salicylic Acid softens and removes thick, scaly skin, enhancing the effectiveness of the corticosteroid. Suitable for localized lesions, it promotes faster healing and relief from discomfort.
